Institute of Genetics and Cancer

Dr Asier Unciti-Broceta's Research: ACS Editors' Choice

ECRC Researcher's recent paper is commended: June 2014

Congratulations to Dr Asier Unciti-Broceta and his team whose recent paper “Development and Bioorthogonal Activation of Palladium-Labile 2 Prodrugs of Gemcitabine" published on the Journal of Medicinal Chemistry, one of the publications from the American Chemical Society (ASC), has been voted as ACS Editors' Choice. Only a small number of the highest quality papers from all ACS journals around the world receive this honour following recommendations by its scientific editors...

Read more